Find a Doctor

Dr. Eugenio Maria Mercuri

Catholic University

Bio


Eugenio Mercuri is in Rome, Italy. Dr. Mercuri is a global expert in Spinal Muscular Atrophy Type 3. They have been an author on 373 peer reviewed articles and participated in 3 clinical trials in the past 15 years. In particular, they have been an author on 41 peer reviewed articles regarding Spinal Muscular Atrophy Type 3. Dr. Mercuri's top three areas of expertise are Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Spinal Muscular Atrophy, and Primary Lateral Sclerosis.

Contact

Rome, IT

Latest Advances


  • Condition: Duchenne Muscular Dystrophy Patients with Left Ventricular Dysfunction
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Sacubitril-Valsartan
  • Number of Patients: 3
  • Published —
The purpose of the study was to assess whether treatment with sacubitril/valsartan is well tolerated and may have beneficial effects in Duchenne Muscular Dystrophy patients with left ventricle dysfunction.
  • Condition: Duchenne muscular dystrophy
  • Journal: Neurology
  • Treatment Used: Golodirsen
  • Number of Patients: 12
  • Published —
The study researched the outcomes of Golodirsen in patients with Duchenne muscular dystrophy.
  • Condition: Type 1 Spinal Muscular Atrophy
  • Journal: The Journal of pediatrics
  • Treatment Used: Nusinersen
  • Number of Patients: 109
  • Published —
The study researched the effects Nusinersen on respiratory health in patients with type 1 spinal muscular atrophy.
  • Condition: Later-Onset Spinal Muscular Atrophy
  • Journal: Muscle & nerve
  • Treatment Used: Nusinersen
  • Number of Patients: 14
  • Published —
This study analyzed the effectiveness of Nusinersen to treat patients with spinal muscular atrophy (SMA; rare neuromuscular disorder).
  • Condition: Type I Spinal Muscular Atrophy
  • Journal: Annals of neurology
  • Treatment Used: Nusinersen
  • Number of Patients: 85
  • Published —
In this study, researchers evaluated the outcomes of using nusinersen for the treatment of type I spinal muscular atrophy in children.
  • Condition: Children With Cerebral Palsy
  • Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • Treatment Used: lycra suits
  • Number of Patients: 5
  • Published —
The purpose of the study was to determine the effectiveness of a lycra suit in improving motor function and static balance in children with cerebral palsy.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Participants: 360
  • Start Date: April 30, 2015
Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care

All Publications
View All


  • Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • Published —
Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
  • Journal: The New England journal of medicine
  • Published —
Risdiplam in Type 1 Spinal Muscular Atrophy.

Contact

Rome, IT

Insurance

Contact them to find out if they accept your insurance plan.